Bonaca MP, Catarig AM, Houlind K, Ludvik B, et al. Semaglutide and walking capacity in people with symptomatic peripheral artery
disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised,
placebo-controlled trial. Lancet 2025 Mar 28:S0140-6736(25)00509-4. doi: 10.1016/S0140-6736(25)00509.
PMID: 40169145
|